Abstract:Somatic cell nuclear transfer (SCNT) has been proved capable of reprogramming various differentiated somatic cells into pluripotent stem cells. Recently, induced pluripotent stem cells (iPS) have been successfully derived from mouse and human somatic cells by the over-expression of a combination of transcription factors. However, the molecular mechanisms underlying the reprogramming mediated by either the SCNT or iPS approach are poorly understood. Increasing evidence indicates that many tumor pathways play roles in the derivation of iPS cells. Embryonal carcinoma (EC) cells have the characteristics of both stem cells and cancer cells and thus they might be the better candidates for elucidating the details of the reprogramming process. Although previous studies indicate that EC cells cannot be reprogrammed into real pluripotent stem cells, the reasons for this remain unclear. Here, nuclei from mouse EC cells (P19) were transplanted into enucleated oocytes and pluripotent stem cells (P19 NTES cells) were subsequently established. Interestingly, P19 NTES cells prolonged the development of tetraploid aggregated embryos compared to EC cells alone. More importantly, we found that the expression recovery of the imprinted H19 gene was dependent on the methylation state in the differential methylation region (DMR). The induction of Nanog expression, however, was independent of the promoter region DNA methylation state in P19 NTES cells. A whole-genome transcriptome analysis further demonstrated that P19 NTES cells were indeed the intermediates between P19 cells and ES cells and many interesting genes were uncovered that may be responsible for the failed reprogramming of P19 cells. To our knowledge, for the first time, we linked incomplete reprogramming to the improved pluripotency of EC cell-derived pluripotent stem cells. The candidate genes we discovered may be useful not only for understanding the mechanisms of reprogramming, but also for deciphering the transition between tumorigenesis and pluripotency.

Resolution of Reprogramming Transition States by Single Cell RNA-Sequencing

Resolving Cell Fate Decisions During Somatic Cell Reprogramming by Single-Cell RNA-Seq.

Global Transcriptional Analysis of Nuclear Reprogramming in the Transition from Mefs to Ipscs

RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming

Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Jdp2-Jhdm1b-Mkk6-Glis1-Nanog-Essrb-Sall4

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Dissecting direct reprogramming through integrative genomic analysis

Transcriptional defects and reprogramming barriers in somatic cell nuclear reprogramming as revealed by single-embryo RNA sequencing

Identifying Candidate Reprogramming Genes in Mouse Induced Pluripotent Stem Cells

Deciphering the decisive factors driving fate bifurcations in somatic cell reprogramming

Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs During Chemical Reprogramming.

Highly Efficient Mirna-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency.

Linking Incomplete Reprogramming to the Improved Pluripotency of Murine Embryonal Carcinoma Cell-Derived Pluripotent Stem Cells

Single-cell analysis of bidirectional reprogramming between early embryonic states reveals mechanisms of differential lineage plasticities

Induction of Pluripotency in Mouse Somatic Cells with Lineage Specifiers

Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells

Single-Cell Transcriptomic Analyses of Cell Fate Transitions During Human Cardiac Reprogramming.

Epigenetic regulation of somatic cell reprogramming

Transcriptional Control of Somatic Cell Reprogramming.

Fine-tuning of iPSC derivation by an inducible reprogramming system at the protein level.

Chromatin Landscape Dynamics During Reprogramming Towards Human Naïve and Primed Pluripotency Reveals the Divergent Function of PRDM1 Isoforms.